Evidence map›Paper›PMID 40636005›Full record

ArticleFrontiers in plant science2025

Identification of DNA N6-methyladenine modifications in the rice genome with a fine-tuned large language model.

Yichi Zhang, Hao Chen, Shicheng Xiang, Zhibin Lv

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yichi ZhangCollege of Biomedical Engineering, Sichuan University, Chengdu, China.
Hao ChenCollege of Biomedical Engineering, Sichuan University, Chengdu, China.
Shicheng XiangCollege of Biomedical Engineering, Sichuan University, Chengdu, China.
Zhibin LvCollege of Biomedical Engineering, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA N6-methyladenine (6mA) plays a significant role in various biological processes. In the rice genome, 6mA is involved in important processes such as growth and development, influencing gene expression. Therefore, identifying the 6mA locus in rice is crucial for understanding its complex gene expression regulatory system. Although several useful prediction models have been proposed, there is still room for improvement. To address this, we propose an architecture named iRice6mA-LMXGB that integrates a fine-tuned large language model to identify the 6mA locus in rice. Specifically, our method consists of two main components: (1) a BERT model for feature extraction and (2) an XGBoost module for 6mA classification. We utilize a pre-trained DNABERT-2 model to initialize the parameters of the BERT component. Through transfer learning, we fine-tune the model on the rice 6mA recognition task, converting raw DNA sequences into high-dimensional feature vectors. These features are then processed by an XGBoost algorithm to generate predictions. To further validate the effectiveness of our fine-tuning strategy, we employ UMAP(Uniform Manifold Approximation and Projection) visualization. Our approach achieves a validation accuracy of 0.9903 in a five-fold cross-validation setting and produces a receiver operating characteristic (ROC) curve with an area under the curve (AUC) of 0.9994. Compared to existing predictors trained on the same dataset, our method demonstrates superior performance. This study provides a powerful tool for advancing research in rice 6mA epigenetics.

Indexed as

BERTlarge language modelN6-methyladeninerice genomeUMAP visualization

Identifiers

PMID40636005
PMCPMC12239757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.